Usefulness of positron emission tomography in predicting long-term outcome in patients with diabetes mellitus and ischemic left ventricular dysfunction

American Journal of Cardiology

Volumn 96, Issue 1, 2005, Pages 2-8

  Sawada, Stephen ^a   Hamoui, Omar ^a   Barclay, Jennifer ^a   Giger, Susan ^a   Fain, Richard ^a   Foltz, Judy ^a   Fineberg, Naomi ^a   Hutchins, Gary ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA N 13; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTIVARIATE ANALYSIS; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 20744452532     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.03.028     Document Type: Article

References (24)

1. N. Tamaki, M. Kawamoto, N. Takahashi, Y. Yonekura, Y. Magata, R. Nohara, H. Kambara, S. Sasayama, K. Hirata, T. Ban, J. Konishi Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction comparison with stress thallium imaging J Am Coll Cardiol 22 1993 1621 1627
2. M.F. Di Carli, M. Davidson, R. Little, S. Khanna, F.V. Mody, R.C. Brunken, J. Czernin, S. Rokhsar, L.W. Stevenson, H. Laks Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction Am J Cardiol 73 1994 527 533
3. D. Eitzman, Z. Al-Aouar, H.L. Kanter, J. vom Dahl, M. Kirsh, G.M. Deeb, M. Schwaiger Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography J Am Coll Cardiol 20 1992 559 565
4. K. Lee, T.H. Marwick, S.A. Cook, R.T. Go, J.S. Fix, K.B. James, S.K. Sapp, W.J. Macintyre, J.D. Thomas Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction relative efficacy of medical therapy and revascularization Circulation 90 1994 2687 2694
5. J.M. Huitink, F.C. Visser, J.J. Bax, A. van Lingen, A.B.J. Groenveld, G.J.J. Teule, C.A. Visser Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction Am J Cardiol 81 1998 1072 1077
6. M.F. Di Carli, J. Maddahi, S. Rokhsar, H.R. Schelbert, D. Bianco-Batles, R.C. Brunken, B. Fromm Long-term survival of patients with coronary artery disease and left ventricular dysfunction implications for the role of myocardial viability assessment in management decisions J Thorac Cardiovasc Surg 116 1998 997 1004
7. J. vom Dahl, C. Altehoefer, F.H. Sheehan, P. Buechin, G. Schulz, E.R. Schwarz, K.C. Koch, R. Uebis, B.J. Messmer, U. Buell, P. Hanrath Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease J Nucl Med 38 1997 742 748
8. F. Haas, C.J. Haehnel, W. Picker, S. Nekolla, S. Martinoff, H. Meisner, M. Schwaiger Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease J Am Coll Cardiol 30 1997 1693 1700
9. M.F. Di Carli, F. Asgarzadie, H.R. Schelbert, R.C. Brunken, H. Laks, M.E. Phelps, J. Maddahi Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy Circulation 92 1995 3436 3444
10. D.L. Dries, N.K. Sweitzer, M.H. Drazner, L.W. Stevenson, B.J. Gersh Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction J Am Coll Cardiol 38 2001 421 438
11. V.H. Thourani, W.S. Weintraub, B. Stein, S.S. Gebhart, J.M. Craver, E.L. Jones, R.A. Guyton Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting Ann Thor Surg 67 1999 1045 1052
12. Y. Cohen, I. Raz, G. Merin, B. Mozes Comparsion of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus Am J Cardiol 81 1998 7 11
13. J. vom Dahl, W.H. Herman, R.J. Hicks, F.J. Ortiz-Alonso, K.S. Lee, K.C. Allman, E.R. Wolfe, V. Kalff, M. Schwaiger Lipids and insulin myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography Circulation 88 1993 395 404
14. T. Ohtake, J. Yokoyama, T. Watanabe, T. Momose, T. Serezawa, J. Nishikawa, Y. Sasaki Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET J Nucl Med 36 1995 456 463
15. K.C. Allman, L.J. Shaw, R. Hachamovitch, J.E. Udelson Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction a meta-analysis J Am Coll Cardiol 39 2002 1151 1158
16. J.J. Bax, F.C. Visser, P.G. Raymakers, A. Van Lingen, J.H. Cornel, J.M. Huitink, A. Elhendy, R.J. Heine, C.A. Visser Cardiac 18F-FDG-SPECT studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping Nucl Med Commun 18 1997 200 206
17. H. Schoder, R. Campisi, T. Ohtake, C.K. Hoh, D.H. Moon, J. Czernin, H.R. Schelbert Blood-flow metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction J Am Coll Cardiol 33 1999 1328 1337
18. R.S.B. Beanlands, P.J. Hendry, R.G. Masters, R.A. deKemp, K. Woodend, T.D. Ruddy Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging Circulation 19 suppl 1998 II-51 II-56
19. The BARI Investigators Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease Circulation 96 1997 1761 1769
20. N.W. Niles, P.D. McGrath, D. Malenka, H. Quinton, D. Wennberg, S.J. Shubrooks, J.F. Tryzelaar, R. Clough, M.J. Hearne, F. Hernandez Northern New England Cardiovascular Disease Study Group Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization results of a large regional prospective study J Am Coll Cardiol 37 2001 1008 1015
21. A. Abizaid, M.A. Costa, M. Centemero, A.S. Abizaid, V.M.G. Legrand, R.V. Limet, G. Schuler, F.W. Mohr, W. Lindebom, A.G.M.R. Sousa Clinical and economic impact of diabetes meillitus on percutaneous and surgical treatment of multivessel coronary disease patients insights from the Arterial Revascularization Therapy Study (ARTS) Trial Circulation 104 2001 533 538
22. S.P. Sedlis, D.A. Morrison, J.D. Lorin, R. Esposito, G. Sethi, J. Sacks, W. Henderson, F. Grover, K.B. Ramanathan, D. Weiman Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass outcome of diabetic patients in the AWESOME randomized trial and registry J Am Coll Cardiol 40 2002 1555 1566
23. K. Yoshida, K.L. Gould Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization J Am Coll Cardiol 22 1993 984 997
24. G.A. Beller Assessing prognosis by means of radionuclide perfusion imaging what technique and which variables should be used? J Am Coll Cardiol 31 1998 1286 1290